Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Zinner, SH' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 34 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zinner, SH; Wise, R; Moellering, RC; Acar, J; Craig, W; Davey, P; Garau, J; Klugman, K; Kristinsson, K; Levin, B; Low, D; MacGowan, A; O'Brien, T; Osterholm, M; Pechere, JC; Phillips, I; Tenover, F; Williams, R; Young, L
      Maximizing Antimicrobial Efficacy/Minimizing Antimicrobial Resistance: A Paradigm for the New Millennium - Proceedings of a Symposium held at the American Academy of Arts and Sciences, Cambridge, Massachusetts, 7-8 December 1999 - General discussion

      CLINICAL INFECTIOUS DISEASES
    2. Zinner, SH; Vostrov, SN; Lubenko, IY; Portnoy, YA; Cornaglia, G; Firsov, AA
      Comparative anti-staphylococcal effects of gemifloxacin and trovafloxacin in an in vitro dynamic model in terms of AUC/MIC and dose relationships

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    3. Firsov, AA; Lubenko, IY; Portnoy, YA; Zinner, SH; Vostrov, SN
      Relationships of the area under the curve/MIC ratio to different integral endpoints of the antimicrobial effect: Gemifloxacin pharmacodynamics in an in vitro dynamic model

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    4. Firsov, AA; Zinner, SH; Lubenko, IY; Vostrov, SN
      Gemifloxacin and ciprofloxacin pharmacodynamics in an in-vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and doses

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    5. Zinner, SH
      New pathogens in neutropenic patients with cancer: an update for the new millennium

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    6. Firsov, AA; Lubenko, IY; Vostrov, SN; Kononenko, OV; Zinner, SH; Portnoy, YA
      Comparative pharmacodynamics of moxifloxacin and levofloxacin in an in vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and equiefficient doses

      Journal of antimicrobial chemotherapy
    7. Vostrov, SN; Kononenko, OV; Lubenko, IY; Zinner, SH; Firsov, AA
      Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: Prediction of equiefficient doses and the breakpoints ofthe area under the curve/MIC ratio

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    8. Zinner, SH; Simmons, K; Gilbert, D
      Comparative activities of ciprofloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro dynamic model

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    9. Margolius, HS; Zinner, SH
      Kallikreins, kinins and the epidemiology of hypertension

      EPIDEMIOLOGY OF HYPERTENSION, VOL 20
    10. Zinner, SH; Firsov, AA
      In vitro dynamic model for determining the comparative pharmacology of fluoroquinolones

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    11. Zinner, SH
      Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria

      CLINICAL INFECTIOUS DISEASES
    12. Firsov, AA; Vasilov, RG; Vostrov, SN; Kononenko, OV; Lubenko, IY; Zinner, SH
      Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacinon staphylococci using an in-vitro dynamic model

      Journal of antimicrobial chemotherapy
    13. Firsov, AA; Vostrov, SN; Kononenko, OV; Zinner, SH; Portnoy, YA
      Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    14. MANDELL LA; CRAVEN D; INGBAR DI; PERCIVAL A; RONALD A; SUMMER WR; TRULOCK EP; WILSON APR; ZINNER SH
      PANEL DISCUSSION - V - THE IMPACT OF ANTIBIOTIC-RESISTANCE ON THE TREATMENT OF RESPIRATORY-INFECTIONS

      Infectious diseases in clinical practice
    15. Zinner, SH
      Relevant aspects in the Infectious Diseases Society of America (IDSA) guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    16. FIRSOV AA; SHEVCHENKO AA; VOSTROV SN; ZINNER SH
      INTERQUINOLONE AND INTRAQUINOLONE PREDICTORS OF ANTIMICROBIAL EFFECT IN AN IN-VITRO DYNAMIC-MODEL - NEW INSIGHT INTO A WIDELY USED CONCEPT

      Antimicrobial agents and chemotherapy
    17. FIRSOV AA; VOSTROV SN; SHEVCHENKO AA; PORTNOY YA; ZINNER SH
      A NEW APPROACH TO IN-VITRO COMPARISONS OF ANTIBIOTICS IN DYNAMIC-MODELS - EQUIVALENT AREA UNDER THE CURVE MIC BREAKPOINTS AND EQUIEFFICIENTDOSES OF TROVAFLOXACIN AND CIPROFLOXACIN AGAINST BACTERIA OF SIMILAR SUSCEPTIBILITIES/

      Antimicrobial agents and chemotherapy
    18. FIRSOV AA; VOSTROV SN; SHEVCHENKO AA; ZINNER SH; CORNAGLIA G; PORTNOY YA
      MIC-BASED INTERSPECIES PREDICTION OF THE ANTIMICROBIAL EFFECTS OF CIPROFLOXACIN ON BACTERIA OF DIFFERENT SUSCEPTIBILITIES IN AN IN-VITRO DYNAMIC-MODEL

      Antimicrobial agents and chemotherapy
    19. ZINNER SH; GILBERT D; DUDLEY MN
      ACTIVITY OF TROVAFLOXACIN (WITH OR WITHOUT AMPICILLIN-SULBACTAM) AGAINST ENTEROCOCCI IN AN IN-VITRO DYNAMIC-MODEL OF INFECTION

      Antimicrobial agents and chemotherapy
    20. Stoupis, A; Zinner, SH
      Approach to fever in the neutropenic host

      MANAGEMENT OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS
    21. ZINNER SH
      ANTIMICROBIAL THERAPY IN CANCER-PATIENTS - STUDIES FROM THE ERNATIONAL-ANTIMICROBIAL-THERAPY-COOPERATIVE-GROUP

      European journal of cancer
    22. FIRSOV AA; RUBLE M; GILBERT D; SAVARINO D; MANZANO B; MEDEIROS AA; ZINNER SH
      NET EFFECT OF INOCULUM SIZE ON ANTIMICROBIAL ACTION OF AMPICILLIN-SULBACTAM - STUDIES USING AN IN-VITRO DYNAMIC-MODEL

      Antimicrobial agents and chemotherapy
    23. PEIPERT JF; DOMAGALSKI L; BOARDMAN L; DAAMEN M; MCCORMACK WM; ZINNER SH
      SEXUAL-BEHAVIOR AND CONTRACEPTIVE USE - CHANGES FROM 1975 TO 1995 IN COLLEGE-WOMEN

      Journal of reproductive medicine
    24. COMETTA AF; CALANDRA T; GAYA H; ZINNER SH; DEBOCK R; DELFAVERO A; BUCANEVE G; CROKAERT F; KERN WV; KLASTERSKY J; LANGENAEKEN J; MICOZZI A; PADMOS A; PAESMANS M; VISCOLI C; GLAUSER MP; MARTINO P; CABALLERO D; ENGELHARD D; SHAPIRO M; CASTAGNOLA E; MASSIMO L; GIACCHINO R; SANZ M; GIGIUM M; CAROTENUTO M; LOPEZ A; ANDRIEN JM; PAULUS R; MARTINO B; NOBILE F; TOGNI P; FERSTER A; CUDILLO L; LEGRAND JC; DINOTA A; CAJOZZO A; QUINTINI G; MARTINEZDALMAU A; NOSARI A; BUCANEVE GP; COMETTA A; GALAZZO M; GIDDEY M; BILLE J; BLASER J
      MONOTHERAPY WITH MEROPENEM VERSUS COMBINATION THERAPY WITH CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER

      Antimicrobial agents and chemotherapy
    25. FIRSOV AA; SAVARINO D; RUBLE M; GILBERT D; MANZANO B; MEDEIROS AA; ZINNER SH
      PREDICTORS OF EFFECT OF AMPICILLIN-SULBACTAM AGAINST TEM-1 BETA-LACTAMASE-PRODUCING ESCHERICHIA-COLI IN AN IN-VITRO DYNAMIC-MODEL - ENZYME-ACTIVITY VERSUS MIC

      Antimicrobial agents and chemotherapy
    26. PEIPERT JF; DOMAGALSKI L; BOARDMAN L; DAAMEN M; ZINNER SH; MCCORMACK WM
      COLLEGE-WOMEN AND CONDOM USE, 1975-1995

      The New England journal of medicine
    27. ZINNER SH
      PROPHYLACTIC USES OF FLUOROQUINOLONE ANTIBIOTICS

      Infectious diseases in clinical practice
    28. ZINNER SH
      UNUSUAL INFECTIONS IN THE IMMUNOCOMPROMISED HOST

      Current opinion in infectious diseases
    29. MCCORMACK WM; ZINNER SH; MCCORMACK WM
      THE INCIDENCE OF GENITOURINARY INFECTIONS IN A COHORT OF HEALTHY WOMEN

      Sexually transmitted diseases
    30. ZINNER SH; CALANDRA T; MEUNIER F; GAYA H; VISCOLI C; KLASTERSKY J; GLAUSER MP; LANGENAKEN J; PAESMANS M; DEBOCK R; VANHOOF A; VANLANDUYT HW; COMETTA A; PADMOS A; VANLIMT MT; PORCELLINI A; RIES F; LOPEZ A; PETRIKKOS G; GIAMARELLOU H; NIKOSKELAINEN J; TSOUSSIS S; VANLAETHEM Y
      REDUCTION OF FEVER AND STREPTOCOCCAL BACTEREMIA IN GRANULOCYTOPENIC PATIENTS WITH CANCER - A TRIAL OF ORAL PENICILLIN-V OR PLACEBO COMBINEDWITH PEFLOXACIN

      JAMA, the journal of the American Medical Association
    31. STRAYER AH; GILBERT DH; PIVARNIK P; MEDEIROS AA; ZINNER SH; DUDLEY MN
      PHARMACODYNAMICS OF PIPERACILLIN ALONE AND IN COMBINATION WITH TAZOBACTAM AGAINST PIPERACILLIN-RESISTANT AND PIPERACILLIN-SUSCEPTIBLE ORGANISMS IN AN IN-VITRO MODEL OF INFECTION

      Antimicrobial agents and chemotherapy
    32. ZINNER SH
      PANIC ATTACKS PRECIPITATED BY SERTRALINE

      The American journal of psychiatry
    33. MARCHBANKS CR; MCKIEL JR; GILBERT DH; ROBILLARD NJ; PAINTER B; ZINNER SH; DUDLEY MN
      DOSE-RANGING AND FRACTIONATION OF INTRAVENOUS CIPROFLOXACIN AGAINST PSEUDOMONAS-AERUGINOSA AND STAPHYLOCOCCUS-AUREUS IN AN IN-VITRO MODEL OF INFECTION

      Antimicrobial agents and chemotherapy
    34. CALANDRA T; ZINNER SH; VISCOLI C; DEBOCK R; GAYA H; MEUNIER F; KLASTERSKY J; GLAUSER MP; NINOVE D; LANGENAEKEN J; PAESMANS M; GALAZZO M; GIDDEY M; BILLE J; HADJDJILANI A; MASSIMO L; MORONI C; CASTAGNOLA E; SANZ M; FERSTER A; DEBOCK R; MEUNIER F; KLASTERSKY J; PADMOS A; GALLAGHER J; COMETTA A; GLAUSER MP; CALANDRA T; LOPEZ A; MARTINEZDALMAU A; POGLIANI E; HEMMER R; DICATO M; RIES F; PORCELLINI A; LEGRAND JC; PORCELLINI A; ESTAVOYER JM; FOLLATH F; SEITANIDES B; ZINNER S; BROWNE M; NIKOSKELAINEN J; ROSSI M; MASERA G
      EFFICACY AND TOXICITY OF SINGLE DAILY DOSES OF AMIKACIN AND CEFTRIAXONE VERSUS MULTIPLE DAILY DOSES OF AMIKACIN AND CEFTAZIDIME FOR INFECTION IN PATIENTS WITH CANCER AND GRANULOCYTOPENIA

      Annals of internal medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 03:54:28